In what can be termed as a significant move, the Food and Drug Administration (FDA) has approved Allergan's INAMED® Silicone-Filled Breast Implants, for breast augmentation, reconstruction and revision surgeries. FDA has banned Silicone filled breast implants long back taking note of safety concerns.

A 4-year data from 715 women involved in the company's Core Clinical Study, which is an ongoing, 10-year prospective, multi-center safety study of women who have undergone breast augmentation, reconstruction or revision surgery, has revealed that silicone filled breast implants as safe. In the Core Clinical Study, less than 1 percent of implants had a reported rupture at 4 years. Upon FDA approval, Allergan will initiate a robust 10-year prospective study referred to as the Breast Implant Follow-up Studies (BIFS) program to further validate the long-term safety and effectiveness of INAMED® Silicone-Filled Breast Implants.

To access the latest information about INAMED® Silicone-Filled Breast Implants and breast implant surgery, or to locate a surgeon who has completed the Allergan Physician Certification Program and has access to the unique INAMED® Matrix of breast implant options,
please visit Allergan's consumer-dedicated Web site at